Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PT Budi Starch & Sweetener Tbk is engaged in industrial food processing and chemical manufacturing. The company produces tapioca starch, sweeteners, sulfuric acid, plastic packaging, and organic fertilizer from cassava, sweet potatoes, coconut palm, and other agricultural products. Commercial operations started in January 1981. The company operates under the Sungai Budi Group umbrella. Main product segments include: Tapioca Starch (largest revenue contributor at 2.715 trillion IDR in 2024), Sweeteners (1.019 trillion IDR in 2024), Sulfuric Acid and Other Chemicals (217 billion IDR in 2024), and Plastic Packaging (195 billion IDR in 2024). The majority of sales are domestic (Indonesia: 3.981 trillion IDR in 2024) with minimal export revenue (28.39 billion IDR in 2024). Major shareholders include PT Budi Delta Swakarya (33.06%) and PT Sungai Budi (26.7%).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PT Budi Starch & Sweetener.